Physician profile
Shashin Shah
NPI 1396944096
$161,711.55
in general payments reported to CMS, 2019-2025
17 companies · $20K in 2025
The $20K reported for 2025 was more than what 95% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $12K · 2021: $10K · 2022: $15K · 2023: $22K · 2024: $66K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $91K · Travel and Lodging: $12K · Food and Beverage: $4,170 · Consulting Fee: $500 · Education: $84.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90,843.75 |
| Travel and Lodging | $12,251.81 |
| Food and Beverage | $4,170.02 |
| Consulting Fee | $500.00 |
| Education | $84.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $47,209.11 | 2020-2023 | |
| Phathom Pharmaceuticals, INC. | $44,125.38 | 2024-2025 | Voquezna |
| Aimmune Therapeutics, INC. | $41,366.17 | 2024-2025 | Zenpep |
| Allergan, INC. | $13,223.97 | 2019-2020 | |
| Gi Supply, INC. | $5,812.50 | 2020-2021 | |
| Covidien Lp | $5,796.16 | 2019-2020 | |
| Boston Scientific Corporation | $1,453.58 | 2019-2025 | Axios, General - Therapies, Overstitch Endoscopic Suturing System |
| Medtronic, INC. | $1,095.95 | 2021-2023 | Gi Genius |
| Ovesco Endoscopy USA, INC. | $612.41 | 2023 | |
| US Endoscopy | $500.00 | 2023 | |
| Apollo Endosurgery US INC | $134.22 | 2019 | |
| Endogastric Solutions, INC | $133.41 | 2019-2024 | Esophyx |
| Abbvie INC. | $95.47 | 2021 | |
| Olympus America INC. | $55.36 | 2019 | |
| Steris Corporation | $52.53 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $28.41 | 2023 | Kcentra |
| Fujifilm Healthcare Americas Corporation | $16.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashin Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.